Atara Biotherapeutics, Inc. (ATRA) has a market capitalization of $42.85M and trades at $5.24. The 52-week range is 3.92-19.145.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 2, Earnings Per Share (EPS) of $2.61, annual revenue of $120.77M.
The stock has a beta of -0.33, operates in the Healthcare sector.
